Leadership & Pay ·
Alamar Biosciences appoints Robert Ragusa to its Board as a Class I Director
ALMRAlamar Biosciences, Inc.
Alamar Biosciences appointed Robert Ragusa to its Board of Directors as a Class I Director effective September 1, 2026, with his term expiring at the 2027 Annual Meeting. He was simultaneously assigned to the Audit, Compensation, and Nominating and Corporate Governance Committees. Compensation follows the existing Non-Employee Director Policy, and standard indemnification agreements were executed. Alamar Biosciences operates in the biotechnology industry, focusing on the development of targeted therapies for cancer.